Keyphrases
Neuroblastoma
100%
Targeted Expression
100%
Molecular Radiotherapy
100%
Immunohistochemical Evaluation
100%
Radiotherapy Target
100%
Somatostatin Receptor 2 (SSTR2)
80%
Transporter Molecules
60%
Noradrenaline Transporter
60%
Tumor
40%
Clinical Information
40%
Expression Score
40%
Clinical Outcomes
20%
Tumor Cells
20%
Clinical Application
20%
Confidence Interval
20%
Treatment Failure
20%
Immunohistochemistry
20%
Monoclonal Antibody
20%
Clinical Data
20%
Eosin
20%
Hematoxylin
20%
Clinical Value
20%
Iodine-131 (131I)
20%
Prospective Evaluation
20%
Correlation Coefficient
20%
Immunohistochemical Assessment
20%
Molecular Targets
20%
Formalin-fixed Paraffin-embedded Tissue
20%
Imaging Assessment
20%
Somatostatin Receptor
20%
123I-MIBG
20%
Tissue Bank
20%
Lutetium DOTATATE
20%
Heterogeneous Imaging
20%
Variable Targets
20%
Lutetium-177 (177Lu)
20%
Medicine and Dentistry
Ganglioneuroblastoma
100%
Radiation Therapy
100%
Noradrenalin
75%
Neoplasm
50%
Tumor Cell
25%
Immunohistochemistry
25%
Monoclonal Antibody
25%
Haematoxylin
25%
Eosin
25%
Iodine 131
25%
(3 Iodobenzyl)guanidine
25%
Lutetium 177
25%
Lutetium
25%
Somatostatin Receptor
25%
Veterinary Science and Veterinary Medicine
Neuroblastoma
100%
Norepinephrine
75%
Neoplasm
75%
Somatostatin
25%
Iodine-131
25%
Monoclonal Antibody
25%